Versiti Acquires Indianapolis-based
Pearl Pathways
Versiti, a national leader in blood health innovation, today announced the acquisition of Pearl Pathways, a recognized trusted advisor and preferred partner for enabling innovative and expedited life science product development.
Biopharma
Medical Devices
Diagnostics
Service Providers
Services to Accelerate Your Therapeutics, Devices, or Diagnostics
We wouldn’t be where we are today without Pearl Pathways. Their advisors’ expertise and flexibility helps keep us on track to overcome obstacles and meet deadlines. They have been there with us through the various ups and downs of our pharma startup.
Snowball Sampling: Is it ethical to pay your study subjects to recruit participants on your behalf?
When new participants are recruited by current participants to become part of a study sample, it is called “snowball sampling.” This is a non-probability sampling technique that can be a practical way to identify and recruit individuals with certain characteristics to...
Regulatory Hurdles: Understanding the Guidelines Governing Radiopharmaceuticals
Radiopharmaceuticals (RPs) are at the forefront of many diagnostic and therapeutic advancements, but the regulations surrounding their development and approval are extensive. Because RPs are appreciably different from standard pharmaceuticals, their regulatory process...
Key Challenges Impacting Radiopharmaceutical Development
Traditionally used in diagnostics, innovative radiopharmaceutical (RP) technology is now increasingly used for therapeutic applications. RPs make for easier and more effective study of various body systems and organs—offering insight into conditions as well as...